Aims In the adult heart, Notch signalling regulates the response to injury. Notch inhibition leads to increased cardiomyocyte apoptosis, and exacerbates the development of cardiac hypertrophy and fibrosis. The role of Notch in the mesenchymal stromal cell fraction, which contains cardiac fibroblasts and cardiac precursor cells, is, however, largely unknown. In the present study, we evaluate, therefore, whether forced activation of the Notch pathway in mesenchymal stromal cells regulates pathological cardiac remodelling. Methods and results We generated transgenic mice overexpressing the Notch ligand Jagged1 on the surface of cardiomyocytes to activate Notch signalling in adjacent myocyte and non-myocyte cells. In neonatal transgenic mice, a...
Aims Notch1 signalling in the heart is mainly activated via expression of Jagged1 on the surface of ...
SummaryFor cell-based treatments of myocardial infarction, a better understanding of key development...
INTRODUCTION: Administration of bone marrow-derived mesenchymal stem cells (MSCs) after myocardial i...
AIMS: In the adult heart, Notch signalling regulates the response to injury. Notch inhibition leads ...
In the damaged heart, cardiac adaptation relies primarily on cardiomyocyte hypertrophy. The recent d...
In the damaged heart, cardiac adaptation relies primarily on cardiomyocyte hypertrophy. The recent d...
Rebuilding the human myocardium following pathological injury remains a significant challenge both a...
RATIONALE: The Notch pathway plays a key role in stimulating mammalian cardiomyocyte proliferation d...
Background—The signaling mechanisms that regulate the recruitment of bone marrow (BM)–derived cells ...
Rationale: Physiological hypertrophy in the developing heart has been considered the product of an i...
The Notch receptor mediates cell fate decision in multiple organs. In the current work we tested the...
Notch signaling is an evolutionarily ancient, highly conserved pathway important for deciding cell f...
AIMS: Notch1 signalling in the heart is mainly activated via expression of Jagged1 on the surface of...
The identification of the molecular mechanisms controlling cardiomyocyte proliferation during the em...
The human heart’s failure to replace ischemia-damaged myocardium with regenerated muscle contributes...
Aims Notch1 signalling in the heart is mainly activated via expression of Jagged1 on the surface of ...
SummaryFor cell-based treatments of myocardial infarction, a better understanding of key development...
INTRODUCTION: Administration of bone marrow-derived mesenchymal stem cells (MSCs) after myocardial i...
AIMS: In the adult heart, Notch signalling regulates the response to injury. Notch inhibition leads ...
In the damaged heart, cardiac adaptation relies primarily on cardiomyocyte hypertrophy. The recent d...
In the damaged heart, cardiac adaptation relies primarily on cardiomyocyte hypertrophy. The recent d...
Rebuilding the human myocardium following pathological injury remains a significant challenge both a...
RATIONALE: The Notch pathway plays a key role in stimulating mammalian cardiomyocyte proliferation d...
Background—The signaling mechanisms that regulate the recruitment of bone marrow (BM)–derived cells ...
Rationale: Physiological hypertrophy in the developing heart has been considered the product of an i...
The Notch receptor mediates cell fate decision in multiple organs. In the current work we tested the...
Notch signaling is an evolutionarily ancient, highly conserved pathway important for deciding cell f...
AIMS: Notch1 signalling in the heart is mainly activated via expression of Jagged1 on the surface of...
The identification of the molecular mechanisms controlling cardiomyocyte proliferation during the em...
The human heart’s failure to replace ischemia-damaged myocardium with regenerated muscle contributes...
Aims Notch1 signalling in the heart is mainly activated via expression of Jagged1 on the surface of ...
SummaryFor cell-based treatments of myocardial infarction, a better understanding of key development...
INTRODUCTION: Administration of bone marrow-derived mesenchymal stem cells (MSCs) after myocardial i...